This compound is a deuterium-labeled active pharmaceutical ingredient derivative of a benzothiazepine structure. It is used as a research compound for pharmaceutical manufacturing and analytical studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1217860-13-3
N-Nitroso-desmethyl-diltiazem
research compound
Xylometazoline hydrochloride
pharmaceutical raw material
Pidotimod
pharmaceutical raw material
Carbovir triphosphate
pharmaceutical raw material
Daptomycin, 9-(2,5-dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine-
pharmaceutical raw material
Diltiazem hydrochloride
pharmaceutical raw material
Diltiazem
pharmaceutical raw material
[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] 2,2,2-trideuterioacetate;hydrochloride
HDRXZJPWHTXQRI-SOOXQBGUSA-N
[2H]C([2H])([2H])C(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl